Standout Papers

Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis... 2004 2026 2011 2018 1.1k
  1. Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B (2005)
    George Lau, Teerha Piratvisuth et al. New England Journal of Medicine
  2. Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B (2004)
    Patrick Marcellin, George Lau et al. New England Journal of Medicine

Immediate Impact

3 by Nobel laureates 2 from Science/Nature 94 standout
Sub-graph 1 of 15

Citing Papers

New Approaches to Chronic Hepatitis B
2023 Standout
Cancer Statistics, 2021
2021 Standout
45 intermediate papers

Works of N. Pluck being referenced

Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B
2005 Standout
Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B
2004 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
N. Pluck 2345 2237 35 160 11 2.4k
Deborah DeHertogh 2408 2205 38 333 21 2.7k
Nancy P. Lam 1405 1535 24 329 13 2.1k
Wendi L. Kuhnert 2141 2114 12 262 20 2.8k
Irene Cacciola 2108 2034 12 158 46 2.3k
Jorge Rakela 1565 1777 9 265 45 2.3k
R. Hindes 2312 2361 40 393 30 2.6k
S.V. Feinman 1785 1870 13 194 36 2.2k
L Viladomiu 1482 1575 19 177 25 1.8k
Anuchit Chutaputti 2107 1919 14 126 29 2.5k
Mitchell Davis 1920 2149 28 415 40 2.5k

All Works

Loading papers...

Rankless by CCL
2026